Wilmington, DE – According to filings with the U.S. Securities and Exchange Commission, Notitia Biotechnologies is raising $1,500,001.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Jeffrey Zhao played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Notitia Biotechnologies

Notitia Biotechnologies (pronounced as “No-tee-sha”) is a microbiome-targeted biotherapeutic company. Our ground-breaking Foundation Guild R&D platform develops therapies that focus on the ecological restoration of the healthy microbiome. Our mission is to help customers recover health by way of promoting and restoring the foundation guild of their gut microbiota. Our vision is to maximize everyone’s healthspan by keeping their gut microbiome to the healthiest possible status for the longest possible time.

To learn more about Notitia Biotechnologies, visit http://www.notitiabio.com/

Contact:
Jeffrey Zhao, Chief Executive Officer
617-642-3114
https://www.linkedin.com/in/jeffrey-zhao-8a6208158/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved